553 related articles for article (PubMed ID: 33132902)
1. Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases.
Tittelmeier J; Nachman E; Nussbaum-Krammer C
Front Aging Neurosci; 2020; 12():581374. PubMed ID: 33132902
[TBL] [Abstract][Full Text] [Related]
2. Protein Quality Control by Molecular Chaperones in Neurodegeneration.
Ciechanover A; Kwon YT
Front Neurosci; 2017; 11():185. PubMed ID: 28428740
[TBL] [Abstract][Full Text] [Related]
3. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
4. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
5. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
6. Involvement of molecular chaperone in protein-misfolding brain diseases.
Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
[TBL] [Abstract][Full Text] [Related]
7. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
Sinnige T; Yu A; Morimoto RI
Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
[TBL] [Abstract][Full Text] [Related]
8. The HSP110/HSP70 disaggregation system generates spreading-competent toxic α-synuclein species.
Tittelmeier J; Sandhof CA; Ries HM; Druffel-Augustin S; Mogk A; Bukau B; Nussbaum-Krammer C
EMBO J; 2020 Jul; 39(13):e103954. PubMed ID: 32449565
[TBL] [Abstract][Full Text] [Related]
9. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
Ries HM; Nussbaum-Krammer C
Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
[TBL] [Abstract][Full Text] [Related]
10. The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases.
Lackie RE; Maciejewski A; Ostapchenko VG; Marques-Lopes J; Choy WY; Duennwald ML; Prado VF; Prado MAM
Front Neurosci; 2017; 11():254. PubMed ID: 28559789
[TBL] [Abstract][Full Text] [Related]
11. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
Luo GR; Le WD
Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
[TBL] [Abstract][Full Text] [Related]
12. Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.
Wang L; Bergkvist L; Kumar R; Winblad B; Pavlov PF
Cells; 2021 Sep; 10(10):. PubMed ID: 34685574
[TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
Bohush A; Bieganowski P; Filipek A
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
[TBL] [Abstract][Full Text] [Related]
15. The role of chaperones in Parkinson's disease and prion diseases.
Winklhofer KF; Tatzelt J
Handb Exp Pharmacol; 2006; (172):221-58. PubMed ID: 16610362
[TBL] [Abstract][Full Text] [Related]
16. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
Fatima MT; Islam Z; Ahmad E; Salahuddin P
Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
[TBL] [Abstract][Full Text] [Related]
17. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
18. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
19. Molecular chaperones biochemistry and role in neurodegenerative diseases.
Chaari A
Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
